Albert C Y Chan Selected Research

Albert C Y Chan Research Topics

Disease

42	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 06/2011
19	Neoplasms (Cancer) 01/2022 - 06/2011
7	Hepatitis B 01/2017 - 10/2011
6	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2014
5	Margins of Excision 02/2022 - 06/2012
4	Rupture 05/2022 - 06/2015
4	Infections 12/2015 - 02/2007
3	Fibrosis (Cirrhosis) 12/2020 - 06/2012
3	End Stage Liver Disease 10/2019 - 12/2013
3	Chronic Hepatitis B 12/2015 - 06/2011
2	Klatskin Tumor 01/2022 - 09/2020
2	Liver Neoplasms (Liver Cancer) 06/2017 - 10/2016
2	Aneurysm (Aneurysms) 06/2015 - 12/2011
2	Thrombosis (Thrombus) 05/2015 - 08/2014
2	Pathologic Constriction (Stenosis) 04/2014 - 02/2013
1	Wounds and Injuries (Trauma) 01/2022
1	Pleural Effusion (Pleural Effusions) 12/2020
1	Hyperbilirubinemia 09/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2019
1	Sepsis (Septicemia) 10/2019
1	Hypoxia (Hypoxemia) 12/2017
1	Disease Progression 06/2017
1	Dyslipidemias (Dyslipidemia) 05/2017
1	Liver Diseases (Liver Disease) 01/2017
1	Hypertrophy 01/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2016
1	Rare Diseases (Rare Disease) 02/2016
1	Brain Death (Brain Dead) 02/2016
1	Abscess 02/2016
1	Hepatitis 12/2015
1	Liver Failure 04/2015
1	Adenocarcinoma 12/2014
1	Cardiac Arrhythmias (Arrythmia) 08/2014
1	Pneumothorax 08/2014
1	Colorectal Neoplasms (Colorectal Cancer) 07/2014
1	Leiomyosarcoma 08/2012
1	Hepatorenal Syndrome 07/2012
1	Transthyretin-Related Hereditary Amyloidosis 03/2012
1	Polyneuropathies (Polyneuropathy) 03/2012
1	Portal Hypertension 12/2011
1	Cough 02/2007
1	Fever (Fevers) 02/2007
1	Opportunistic Infections (Opportunistic Infection) 02/2007
1	Tuberculosis (Tuberculoses) 02/2007

Drug/Important Bio-Agent (IBA)

3	Antiviral Agents (Antivirals)IBA 04/2016 - 06/2011
3	Immunoglobulins (Immunoglobulin)IBA 04/2016 - 10/2011
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2022 - 06/2021
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2016 - 12/2015
1	BilirubinIBA 09/2020
1	Carcinoembryonic AntigenIBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	AntibodiesIBA 01/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2018
1	Alanine Transaminase (SGPT)IBA 11/2018
1	ChromatinIBA 12/2017
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	Therapeutic UsesIBA 06/2017
1	CyclinsIBA 06/2017
1	Cyclin D1IBA 06/2017
1	hepatitis B hyperimmune globulinIBA 12/2015
1	DNA (Deoxyribonucleic Acid)IBA 12/2015
1	Yttrium-90IBA 08/2014
1	ElectrolytesIBA 08/2014
1	Capsules (Microcapsules)IBA 12/2012
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 06/2012
1	entecavir FDA Link 10/2011
1	NucleosidesIBA 10/2011
1	GuanosineIBA 10/2011

Therapy/Procedure

26	Liver Transplantation 01/2022 - 02/2007
24	Hepatectomy 05/2022 - 06/2011
9	Therapeutics 11/2021 - 06/2011
9	Transplantation 11/2021 - 02/2007
9	Radiofrequency Ablation 01/2020 - 01/2012
6	Drug Therapy (Chemotherapy) 02/2022 - 06/2012
4	Ligation 01/2022 - 12/2011
4	High-Intensity Focused Ultrasound Ablation 08/2014 - 10/2012
3	Blood Transfusion (Blood Transfusions) 05/2018 - 06/2012
2	Length of Stay 12/2020 - 01/2020
2	Extracorporeal Shockwave Therapy 07/2014 - 04/2013
1	Laparoscopic Cholecystectomy 01/2022
1	Radiotherapy 01/2020
1	Pancreaticoduodenectomy 12/2014
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2011
1	Surgical Splenorenal Shunt (Splenorenal Shunt) 12/2011